Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.52 USD | -3.17% |
|
+5.21% | +34.19% |
Jan. 17 | Walgreens Shares Fall After Justice Department Files Opioid Lawsuit | DJ |
Jan. 17 | U.S. Sues Walgreens For Role in Opiod Crisis | DJ |
Capitalization | 10.82B 10.4B 9.82B 8.8B 15.49B 933B 17.28B 119B 44.22B 385B 40.58B 39.74B 1,684B | P/E ratio 2025 * |
-21.6x | P/E ratio 2026 * | -47.4x |
---|---|---|---|---|---|
Enterprise value | 18.07B 17.37B 16.4B 14.69B 25.87B 1,557B 28.85B 199B 73.84B 643B 67.76B 66.36B 2,812B | EV / Sales 2025 * |
0.12x | EV / Sales 2026 * | 0.12x |
Free-Float |
60.68% | Yield 2025 * |
7.99% | Yield 2026 * | 7.99% |
Last Transcript: Walgreens Boots Alliance, Inc.
1 day | -3.17% | ||
1 week | +5.21% | ||
Current month | +34.19% | ||
1 month | +31.10% | ||
3 months | +16.03% | ||
6 months | +13.71% | ||
Current year | +34.19% |







Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 2023-10-22 | |
Manmohan Mahajan
DFI | Director of Finance/CFO | 46 | 2023-07-26 |
Neal Sample
CTO | Chief Tech/Sci/R&D Officer | 50 | 2023-09-30 |
Manager | Title | Age | Since |
---|---|---|---|
Stefano Pessina
CHM | Chairman | 84 | 2021-03-14 |
Jan Babiak
BRD | Director/Board Member | 67 | 2012-03-31 |
Director/Board Member | 70 | 2006-09-30 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-3.17% | +5.21% | -43.09% | -76.46% | 10.82B | ||
+2.53% | +7.04% | +14.29% | -57.06% | 12.19B | ||
+2.66% | +4.19% | +16.00% | -49.86% | 6.99B | ||
+0.40% | +3.99% | -17.39% | +76.61% | 5.85B | ||
-0.40% | +0.73% | +21.71% | +20.90% | 4.77B | ||
-0.34% | +0.51% | -16.12% | - | 4.11B | ||
+1.20% | -2.23% | -27.88% | -27.99% | 3.93B | ||
+2.61% | +5.95% | -4.28% | -27.54% | 2.96B | ||
+8.38% | +1.71% | +16.75% | +80.43% | 2.78B | ||
+1.26% | +7.00% | -5.40% | +8.54% | 2.56B | ||
Average | +1.42% | +2.95% | -4.54% | -5.83% | 5.69B | |
Weighted average by Cap. | +0.91% | +3.93% | -5.87% | -24.03% |
2025 * | 2026 * | |
---|---|---|
Net sales | 152B 146B 138B 123B 217B 13,095B 243B 1,675B 621B 5,402B 570B 558B 23,646B | 155B 149B 140B 126B 221B 13,331B 247B 1,706B 632B 5,500B 580B 568B 24,073B |
Net income | -679M -652M -616M -552M -972M -58.5B -1.08B -7.48B -2.77B -24.13B -2.54B -2.49B -106B | -480M -462M -436M -390M -688M -41.4B -767M -5.3B -1.96B -17.08B -1.8B -1.76B -74.75B |
Net Debt | 7.25B 6.97B 6.58B 5.89B 10.38B 625B 11.57B 79.92B 29.62B 258B 27.18B 26.62B 1,128B | 7.13B 6.86B 6.47B 5.8B 10.21B 615B 11.39B 78.66B 29.15B 254B 26.75B 26.19B 1,110B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-17 | 12.52 $ | -3.17% | 34,974,425 |
25-01-16 | 12.93 $ | +3.19% | 18,807,048 |
25-01-15 | 12.53 $ | +2.37% | 24,092,759 |
25-01-14 | 12.24 $ | +2.86% | 33,235,713 |
Delayed Quote Nasdaq, January 17, 2025 at 04:00 pm EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WBA Stock